Genomic testing for differences of sex development: Practices and perceptions of clinicians
Clinical Endocrinology · 2024
DOI: 10.1111/cen.15123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology, 2024. Verfasst von Gabby Atlas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Murdoch Children's Research Institute, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Genetic Testing, Disorders of Sex Development. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
To investigate the approach taken by clinicians involved in the diagnosis and management of individuals with Differences of Sex Development (DSD), particularly with regard to genomic testing, and identify perceived gaps/strengths/barriers in current practice. Design and Methods An anonymous online survey was developed, with questions exploring demographics, perceptions of genomic testing, availability of genetics services and opinions on the role and utility of genomic testing in DSD. All responses were anonymous. Clinicians involved in the diagnosis and management of individuals with DSD were recruited from relevant societies and departments across Australia and New Zealand.
Results
79 eligible clinicians commenced the survey, with 63 completing it and 16 providing a partial response. The perceived benefit of having a genetic diagnosis for DSD was almost unanimous (97%). Almost half (48%) of respondents reported barriers in genomic testing. 81% of respondents reported they order genomic tests currently. Approaches to genomic testing when faced with four different clinical scenarios varied across respondents. Clinicians perceived genomic testing to be underutilised (median 36 on sliding scale from 0 to 100).
Conclusions
Despite 97% of respondents reporting benefit of a genetic diagnosis for individuals with DSD, this was not reflected throughout the survey with regard to clinical implementation. When faced with clinical scenarios, the recommendations for genomic testing from respondents was much lower, indicating the discrepancy between perception and clinical practice. Genomic testing in the context of DSD is seen as both beneficial and desired, yet there are multiple barriers impacting its integration into standard clinical care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Murdoch Children's Research Institute, Parkville, Victoria, Australia.
- Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.
- Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.
- Victorian Clinical Genetics Services, Parkville, Victoria, Australia.
Zitieren
APA
Atlas, G., Hanna, C., Tan, T. Y., Nisselle, A., Tucker, E., Ayers, K., Sinclair, A., & O'Connell, M. A. (2024). Genomic testing for differences of sex development: Practices and perceptions of clinicians. Clinical Endocrinology. https://doi.org/10.1111/cen.15123
Vancouver
Atlas G, Hanna C, Tan TY, Nisselle A, Tucker E, Ayers K, et al. Genomic testing for differences of sex development: Practices and perceptions of clinicians. Clinical Endocrinology. 2024. doi:10.1111/cen.15123
BibTeX
@article{Atlas2024,
author = {Atlas, Gabby and Hanna, Chloe and Tan, Tiong Yang and Nisselle, Amy and Tucker, Elena and Ayers, Katie and Sinclair, Andrew and O'Connell, Michele A},
title = {Genomic testing for differences of sex development: Practices and perceptions of clinicians},
journal = {Clinical Endocrinology},
year = {2024},
doi = {10.1111/cen.15123}
}
EUVIMED